Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periodontal status of Rheumatoid Arthritis patients under rituximab treatment: case-control study
TCTR20191215003Completed
- Sponsor
- Akdeniz University
- Start
- Nov 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of rituximab in rheumatoid arthritis (RA) (2 arms), sponsored by Akdeniz University. Primary endpoint: Periodontal status. Started Nov 2017; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on TCTR20191215003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191215003.